Literature DB >> 34434566

Role of whole brain radiotherapy in the management of infratentorial metastases from lung and breast cancer.

Bernardo Cacho-Díaz1, Alejandra Alvarez-Alvarez1, Karen Salmerón-Moreno1, Oscar Rodríguez-Mayoral2, Bernardino Gabriel Santiago-Concha3, Oscar G Arrieta Rodríguez4.   

Abstract

BACKGROUND: Brain metastases (BM) occur in almost one third of patients with systemic malignancies. Only a small number of studies focus on infratentorial location and whole brain radiotherapy (WBRT) as the main non-surgical management. The aim of the study was to compare the prognosis of patients treated with WBRT among patients with supra- or infratentorial lesions.
MATERIALS AND METHODS: At a single center, 263 patients with either breast (BC) or lung (LC) cancer, that had developed BM and received treatment with WBRT, were analyzed during an 8-year period.
RESULTS: A total of 152 patients with BC and 111 with LC were analyzed, median age at the time of BM was 50.7 years, systemic activity other than BM was detected in 91%. Newly diagnosed BM were supratentorial in 40%, infratentorial in 10% and 51% in both locations. Median overall survival was 13 months (95% CI: 11.1-14.8 months), without significant difference between supra- or infratentorial location. WBRT alone was administered in 79% of patients, whereas WBRT with chemtoreapy was provided for 21%.
CONCLUSION: In patients with BM from LC or BC that were not candidates for surgical resection, palliative WBRT appears to be equally effective in those with supra- or infratentorial locations.
© 2021 Greater Poland Cancer Centre.

Entities:  

Keywords:  breast cancer; infratentorial; lung cancer; palliative care; radiotherapy; whole-brain radiotherapy

Year:  2021        PMID: 34434566      PMCID: PMC8382077          DOI: 10.5603/RPOR.a2021.0060

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  12 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis.

Authors:  Luca Nicosia; Vanessa Figlia; Rosario Mazzola; Giuseppe Napoli; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Gianluigi Lunardi; Davide Tomasini; Marco L Bonù; Stefanie Corradini; Ruggero Ruggieri; Filippo Alongi
Journal:  Clin Exp Metastasis       Date:  2019-11-06       Impact factor: 5.150

3.  Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.

Authors:  Masaaki Yamamoto; Takuya Kawabe; Yasunori Sato; Yoshinori Higuchi; Tadashi Nariai; Shinya Watanabe; Hidetoshi Kasuya
Journal:  J Neurosurg       Date:  2014-12       Impact factor: 5.115

4.  Distribution of brain metastases: implications for non-uniform dose prescriptions.

Authors:  E T Bender; W A Tomé
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

Review 5.  Brain metastases.

Authors:  Jaime Gállego Pérez-Larraya; Jerzy Hildebrand
Journal:  Handb Clin Neurol       Date:  2014

Review 6.  Current approaches to the management of brain metastases.

Authors:  John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang
Journal:  Nat Rev Clin Oncol       Date:  2020-02-20       Impact factor: 66.675

Review 7.  Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.

Authors:  May N Tsao; Wei Xu; Rebecca Ks Wong; Nancy Lloyd; Normand Laperriere; Arjun Sahgal; Eileen Rakovitch; Edward Chow
Journal:  Cochrane Database Syst Rev       Date:  2018-01-25

Review 8.  The effect of brain metastasis location on clinical outcomes: A review of the literature.

Authors:  Pragnan Kancharla; Alexander Ivanov; Susie Chan; Hani Ashamalla; Raymond Y Huang; Ted K Yanagihara
Journal:  Neurooncol Adv       Date:  2019-09-13

Review 9.  Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials.

Authors:  Shuai Qie; Yanhong Li; Hong-Yun Shi; Lanhui Yuan; Lei Su; Xi Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

10.  Surgical management of posterior fossa metastases.

Authors:  Geraint J Sunderland; Michael D Jenkinson; Rasheed Zakaria
Journal:  J Neurooncol       Date:  2016-09-12       Impact factor: 4.130

View more
  1 in total

Review 1.  Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies.

Authors:  Margarita Martin; Raúl Hernanz; Carmen Vallejo; Leonardo Guerrero; Xabier Mielgo; Ana Lopez; Juan Carlos Trujillo-Reyes; Felipe Couñago
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.